๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Selected Advanced Solid Tumors

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors NCT07814248Phase 13 sites๐Ÿ“ Maumee๐Ÿ“ Portland๐Ÿ“ Fairfax TwoStep Therapeutics, Inc. ยท Tests: TS-104 PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors NCT07510828Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-PT-CAR-NK-S, EB-PT-CAR-NK-D, Lymphodepleting chemotherapy, Cytokine support A Study of BG-C477 in Participants With Advanced Solid Tumors NCT06596473Phase 159 sites๐Ÿ“ Goodyear๐Ÿ“ Duarte๐Ÿ“ Aurora BeOne Medicines ยท Tests: BG-C477, Tislelizumab, Chemotherapy A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors NCT06747585Phase 1, Phase 241 sites๐Ÿ“ Scottsdale๐Ÿ“ Fullerton๐Ÿ“ Los Angeles Alentis Therapeutics AG ยท Tests: ALE.P02, Pembrolizumab First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors NCT06402201Phase 120 sites๐Ÿ“ Miami๐Ÿ“ Ann Arbor๐Ÿ“ Portland CDR-Life AG ยท Tests: CDR404 Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations NCT06581432Phase 292 sites๐Ÿ“ Anchorage๐Ÿ“ Tucson๐Ÿ“ Beverly Hills Boehringer Ingelheim ยท Tests: Zongertinib Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors NCT04643418Phase 1, Phase 21 site๐Ÿ“ Taipei MegaPro Biomedical Co. Ltd. ยท Tests: MPB-1734 A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors NCT07600476Phase 13 sites๐Ÿ“ Munich๐Ÿ“ Wรผrzburg๐Ÿ“ Mรผnster Kupando GmbH ยท Tests: KUP-101A Clinical Trial of PM54 in Advanced Solid Tumors Patients. NCT05841563Phase 13 sites๐Ÿ“ San Antonio๐Ÿ“ Anderlecht๐Ÿ“ Madrid PharmaMar ยท Tests: PM54 AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors NCT07454642Phase 17 sites๐Ÿ“ Scottsdale๐Ÿ“ Sarasota๐Ÿ“ Chicago Avacta Life Sciences Ltd ยท Tests: AVA6103 Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial) NCT06311214Phase 229 sites๐Ÿ“ Duarte๐Ÿ“ Encinitas๐Ÿ“ Irvine National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Electronic Health Record Review A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours NCT06725758Phase 1, Phase 220 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ St Louis Orion Corporation, Orion Pharma ยท Tests: ODM-212 A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors NCT07414836Phase 118 sites๐Ÿ“ Boston๐Ÿ“ St Louis๐Ÿ“ Hackensack BeOne Medicines ยท Tests: BG-C0979, Tislelizumab A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3 NCT07807241Phase 17 sites๐Ÿ“ Sarasota๐Ÿ“ Atlanta๐Ÿ“ Baltimore Myricx Pharma Limited ยท Tests: MX006 ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors NCT07158918Phase 1, Phase 26 sites๐Ÿ“ Cleveland๐Ÿ“ Frankston๐Ÿ“ Seongnam ABL Bio, Inc. ยท Tests: ABL103, KEYTRUDAยฎ (pembrolizumab), Taxane A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors NCT07141706Phase 114 sites๐Ÿ“ Los Angeles๐Ÿ“ Ann Arbor๐Ÿ“ Pittsburgh DualityBio Inc. ยท Tests: DB-1317 An Engineered Sirpฮฑ Fused to Anti-Pd-L1 And Tgf-ฮฒ Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors NCT06487624Phase 17 sites๐Ÿ“ Greenville๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou FBD Biologics Limited ยท Tests: HCB301 A Study of Sovilnesib in Subjects With Ovarian Cancer NCT06084416Phase 111 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ Newport Beach Volastra Therapeutics, Inc. ยท Tests: Sovilnesib Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer NCT07462650Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-DUO-CAR-NK-CEA/GCC (IV) Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial NCT05564377Phase 2484 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Anchorage National Cancer Institute (NCI) ยท Tests: Alpelisib, Binimetinib, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration AMT-253 in Patients With Selected Advanced Solid Tumours NCT05906862Phase 17 sites๐Ÿ“ Sydney๐Ÿ“ Sydney๐Ÿ“ Sydney Multitude Therapeutics (Australia) Pty Ltd ยท Tests: AMT-253 A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) NCT03767075Phase 28 sites๐Ÿ“ Villejuif๐Ÿ“ Heidelberg๐Ÿ“ Dresden Vall d'Hebron Institute of Oncology ยท Tests: Atezolizumab, Futibatinib, Amivantamab A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors NCT07612176Phase 19 sites๐Ÿ“ New York๐Ÿ“ Nashville๐Ÿ“ Austin NEOK Bio, Inc. ยท Tests: NEOK001, NEOK001 RDE A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies NCT05473156Phase 1, Phase 21 site๐Ÿ“ Taipei AP Biosciences Inc. ยท Tests: AP203, AP203 SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors NCT07812805Phase 15 sites๐Ÿ“ Glen Burnie๐Ÿ“ Pittsburgh๐Ÿ“ Seoul SK Life Science, Inc. ยท Tests: SKL35501, SKL35502 A Study of LY4175408 in Participants With Advanced Cancer NCT07046923Phase 127 sites๐Ÿ“ Stanford๐Ÿ“ Orlando๐Ÿ“ Sarasota Eli Lilly and Company ยท Tests: LY4175408, Pembrolizumab, Carboplatin, Cisplatin Physician and Patient Preferences for Cell Therapies in Advanced Solid Tumors NCT07813000n/a1 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: Not applicable- observational study A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors NCT06803680Phase 111 sites๐Ÿ“ Celebration๐Ÿ“ Philadelphia๐Ÿ“ Sioux Falls BeOne Medicines ยท Tests: BGB-B455, Chemotherapy A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors NCT06598371Phase 1, Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Cyclophosphamide, Fludarabine, KSQ-004EX, Interleukin-2
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy